sacituzumab
gilead sciences
['paradigm', 'sacituzumab', 'tropics-02', 'breast', 'rs onco']
esmo 2022 video: hope rugo outlines the latest results from the tropics-02 trial of sacituzumab govitecan in hr+, her2 advanced breast cancer and discusses where sacituzumab fits into the treatment paradigm.
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.